(Q33781308)

29 July 2017

title

Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence (English)

1 reference

29 July 2017

1 reference

1 reference

Shingo Tanaka

1

1 reference

29 July 2017

Mitsutoshi Nakada

2

1 reference

29 July 2017

Yutaka Hayashi

3

1 reference

29 July 2017

Satoko Nakada

4

1 reference

29 July 2017

Seiko Sawada-Kitamura

5

1 reference

29 July 2017

Natsuki Furuyama

6

1 reference

29 July 2017

Tomohide Suzuki

7

1 reference

29 July 2017

Tomoya Kamide

8

1 reference

29 July 2017

Yasuhiko Hayashi

9

1 reference

29 July 2017

Seiji Yano

10

1 reference

29 July 2017

Jun-ichiro Hamada

11

1 reference

29 July 2017

publication date

25 December 2010

1 reference

29 July 2017

published in

Brain Tumor Pathology

1 reference

29 July 2017

volume

28

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

59-64

1 reference

Epithelioid glioblastoma: a case report.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Adenoid glioblastoma arising in a patient with neurofibromatosis type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0009-X

10.1007/S10014-010-0009-X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference